Qube Research & Technologies (QRT)
HALO icon

Qube Research & Technologies (QRT)’s Halozyme HALO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-412,421
Closed -$27.8M – 3771
2025
Q4 		$27.8M Sell
412,421
-188,855
-31% -$12.7M 0.03% 751
2025
Q3 		$44.1M Sell
601,276
-384,793
-39% -$25.6M 0.05% 518
2025
Q2 		$51.3M Buy
+986,069
New +$56.1M 0.05% 454
2025
Q1 		– Sell
-245,750
Closed -$11.7M – 3634
2024
Q4 		$11.7M Buy
245,750
+17,644
+8% +$905K 0.02% 998
2024
Q3 		$13.1M Buy
228,106
+187,234
+458% +$10.7M 0.02% 881
2024
Q2 		$2.14M Sell
40,872
-322,467
-89% -$14.1M ﹤0.01% 1585
2024
Q1 		$14.8M Buy
363,339
+108,026
+42% +$4.05M 0.02% 676
2023
Q4 		$9.44M Buy
255,313
+229,532
+890% +$8.64M 0.02% 757
2023
Q3 		$985K Sell
25,781
-112,574
-81% -$4.61M ﹤0.01% 1730
2023
Q2 		$4.99M Buy
138,355
+119,311
+627% +$4.07M 0.02% 700
2023
Q1 		$727K Sell
19,044
-85,672
-82% -$4.02M ﹤0.01% 1417
2022
Q4 		$5.96M Buy
+104,716
New +$5.36M 0.03% 616
2022
Q3 		– Sell
-53,329
Closed -$2.35M – 2699
2022
Q2 		$2.35M Buy
+53,329
New +$2.31M 0.02% 749
2021
Q4 		– Sell
-10,153
Closed -$413K – 2700
2021
Q3 		$413K Sell
10,153
-11,579
-53% -$484K 0.01% 1311
2021
Q2 		$987K Sell
21,732
-28,322
-57% -$1.25M 0.01% 940
2021
Q1 		$2.09M Sell
50,054
-11,438
-19% -$522K 0.03% 610
2020
Q4 		$2.63M Buy
61,492
+49,219
+401% +$1.77M 0.04% 513
2020
Q3 		$323K Sell
12,273
-4,838
-28% -$135K ﹤0.01% 1210
2020
Q2 		$459K Buy
+17,111
New +$386K 0.01% 1149
2020
Q1 		– Sell
-73,897
Closed -$1.31M – 1353
2019
Q4 		$1.31M Buy
+73,897
New +$1.28M 0.04% 503

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HALO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Halozyme (HALO) in Q1 2026, closing a stake of 412,421 shares — an estimated $27.8M sold.

Qube Research & Technologies (QRT) first reported a position in HALO in Q4 2019 and held it in 20 quarters. The position peaked at $51.3M in Q2 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 412,421 Halozyme shares in Q1 2026, an estimated $27.8M.
  • Qube Research & Technologies (QRT) first reported a position in Halozyme in Q4 2019 and held it in 20 quarters.
  • Qube Research & Technologies (QRT)'s Halozyme position peaked at $51.3M in Q2 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.